Âé¶ą´«Ă˝É«ÇéƬ

Journal News

Researchers get to the bottom of noninvasive gut tests

Mucus contains vital data to help address diseases such as inflammatory bowel disease and colon cancer
David Bidwell
By David Bidwell
March 3, 2024

New research from the University of British Columbia Okanagan, recently in the Journal of Biological Chemistry could make monitoring gut health easier and less painful by tapping into a common — yet often overlooked — source of information: the mucus in our digestive system that eventually becomes part of fecal matter.

Correct, what’s in our poop.

close-up of man holding his abdomen.
Liubomyr Vorona
New research from UBC Okanagan showed that noninvasive techniques can return vital gut health data from the mucus in our fecal matter.

Biology researcher Kirk Bergstrom and master’s student Noah Fancy found a noninvasive technique to study MUC2, a critical gut protein, from what we leave behind in the bathroom.

“MUC2 is like the silent star in our guts. It’s constantly working to protect us, and its proper functioning is crucial for our overall health,” Bergstrom said. “It was originally thought that you could only access this important molecule from biopsies or tissue removed via surgery — highly invasive and painful procedures.

“However, our study shows mucus is actually a part of our stool, meaning we can get at it painlessly and at levels we could not before. Anytime we can do analysis noninvasively, it’s a win.”

Clues to health can be found in unexpected places, and Bergstrom’s team found a way to study important gut health markers from fecal-adherent mucus — a term that, in simpler words, refers to the mucus attached to our stool. This mucus, typically ignored and flushed away, contains a trove of information about gut health.

MUC2, a glycoprotein with many sugar chains attached, forms a protective barrier in our intestines in the form of mucus, safeguarding our gut from harmful microbes and toxins and playing a crucial role in digestive health.

Understanding MUC2 better could lead to significant advancements in managing and preventing gut-related diseases, impacting the day-to-day well-being of millions.

“We can use these new methods to visualize mucus–microbiota interactions and how they go wrong in various diseases, like inflammatory bowel diseases and colon cancer,” Bergstrom noted.  “The sugars on the mucins also carry lots of information on the health status of the colon.”

Fancy led the work, which was the result of a strong collaborative effort between the Bergstrom Lab and the chemistry lab of Wesley Zandberg and the biology labs of Sepideh Pakpour, Deanna Gibson and Sanjoy Ghosh, all at UBC Okanagan.

This article was originally published in the . You can read the original.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
David Bidwell
David Bidwell

David Bidwell is a writer and content strategist, University Relations, University of British Columbia Okanagan.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer’s spaghetti proteins
Profile

Unraveling cancer’s spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Profile

How HCMV hijacks host cells — and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Profile

Understanding the lipid link to gene expression in the nucleus

Aug. 11, 2025

Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.

Receptor antagonist reduces age-related bone loss in mice
Journal News

Receptor antagonist reduces age-related bone loss in mice

Aug. 6, 2025

Receptor antagonist reduces bone loss and promotes osteoblast activity in aging mice, highlighting its potential to treat osteoporosis. Read more about this recent JBC paper.

Engineered fusion protein targets kiwifruit pathogen
Journal News

Engineered fusion protein targets kiwifruit pathogen

Aug. 6, 2025

Synthetic protein selectively kills kiwifruit pathogen, offering a promising biocontrol strategy for agriculture. Read more about this recent JBC paper.